IKCS 2019: Treatment-Free Survival With and Without Toxicity With Nivolumab and Ipilimumab in Metastatic Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.